Alebund Pharmaceuticals is based in Shanghai, China. It has raised $60M in total funding. Latest round: Series B.
Alebund Pharmaceuticals is based in Shanghai, China. Alebund Pharmaceuticals has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in May 2021. The round record for Alebund Pharmaceuticals runs through 2021; nothing later has been disclosed. Investors on record include Quan Capital, 3E Bioventures Capital, Sherpa Healthcare Partners, Lilly Asia Ventures, Med-Fine Capital. 5 distinct backers are named across the disclosed rounds.
Round data for Alebund Pharmaceuticals is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Shanghai and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026